Request Appointment
353 East 68th StreetNew York, NY 10065
Overview of Dr. Donahue
Dr. Timothy Donahue is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Boston University School of Medicine and has been in practice 31 years. He is one of 87 doctors at Memorial Sloan Kettering Cancer Center and one of 16 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Urology. He has more than 60 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2012 - 2014
National Capital ConsortiumResidency, Urology, 1997 - 2001- National Capital ConsortiumInternship, Transitional Year, 1995 - 1996
Boston University School of MedicineClass of 1995
Certifications & Licensure
NY State Medical License 2012 - 2027
MD State Medical License 1997 - 2016
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2017
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2017
Clinical Trials
- Fluorescent Imaging of Nerves With Illuminare-1 During Surgery Start of enrollment: 2021 Oct 04
Publications & Presentations
PubMed
- 1 citationsUrinary Biomarkers Objectively Measure Minimal Residual Disease in Non-Muscle-Invasive Bladder Cancer.Andrew B Katims, Charlie White, Syed Muneeb Alam, Mark Farha, Sadra Sepehri
Clinical Cancer Research. 2026-05-01 - 1 citationsNeoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer.Brendan J Guercio, Eugene J Pietzak, Vignesh Ravichandran, Jie-Fu Chen, Ronak H Shah
Clinical Cancer Research. 2026-04-15 - 7 citationsNeoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort.Viranda H Jayalath, Melissa Assel, Gopa Iyer, Scot Niglio, Bernard H Bochner
European Urology. 2026-02-01
Press Mentions
Could Common Blood Pressure Meds Help Curb Pancreatic Cancer?February 25th, 2022- Combination Therapy Suppresses Pancreatic Tumour Growth: StudyFebruary 25th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
